GlassScriptPhysician profile
Jennifer Lee Bain
NPI 1487230660
$2,339.83
in general payments reported to CMS, 2019-2025
15 companies · $793 in 2025
The $793 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.99 · 2022: $615 · 2023: $421 · 2024: $453 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,666.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,097.06 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Mycarelink |
| Boston Scientific Corporation | $541.85 | 2022-2025 | Watchman Flx, Watchman Access System, Cds - Mct/Cem Monitoring |
| Pfizer INC. | $179.76 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $126.59 | 2025 | Camzyos, Eliquis |
| Cvrx, INC. | $84.87 | 2023-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.06 | 2024-2025 | Lifevest |
| Atricure, INC. | $40.10 | 2024 | |
| Amgen INC. | $37.91 | 2023-2024 | Repatha |
| Novo Nordisk INC | $31.18 | 2025 | Wegovy |
| Cardiva Medical, INC. | $30.35 | 2022 | |
| Janssen Pharmaceuticals, INC | $29.50 | 2023 | Xarelto |
| Cordis US Corp. | $26.28 | 2025 | Mynx Control Venous |
| Scpharmaceuticals INC. | $25.83 | 2025 | |
| Irhythm Technologies, INC. | $20.39 | 2023 | Zio Xt Patch |
| Novartis Pharmaceuticals Corporation | $17.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Bain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.